United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund grew its position in McKesson Corporation (NYSE:MCK - Free Report) by 219.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 11,504 shares of the company's stock after purchasing an additional 7,904 shares during the quarter. United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund's holdings in McKesson were worth $9,437,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also modified their holdings of the company. GGM Financials LLC acquired a new stake in shares of McKesson in the 3rd quarter valued at $25,000. State of Wyoming acquired a new stake in McKesson during the second quarter worth approximately $29,000. Hopwood Financial Services Inc. acquired a new stake in McKesson during the third quarter worth approximately $31,000. Board of the Pension Protection Fund acquired a new stake in McKesson during the fourth quarter worth approximately $33,000. Finally, Kingdom Financial Group LLC. acquired a new stake in McKesson during the fourth quarter worth approximately $33,000. 85.07% of the stock is currently owned by institutional investors and hedge funds.
McKesson Stock Performance
Shares of McKesson stock opened at $757.80 on Friday. McKesson Corporation has a 1 year low of $637.00 and a 1 year high of $999.00. The company has a market capitalization of $91.09 billion, a P/E ratio of 19.70, a PEG ratio of 1.13 and a beta of 0.35. The company's fifty day moving average is $823.51 and its two-hundred day moving average is $853.22.
McKesson (NYSE:MCK - Get Free Report) last announced its quarterly earnings data on Thursday, May 7th. The company reported $11.69 earnings per share (EPS) for the quarter, beating the consensus estimate of $11.56 by $0.13. The company had revenue of $96.30 billion for the quarter, compared to analysts' expectations of $101.35 billion. McKesson had a net margin of 1.18% and a negative return on equity of 345.35%. McKesson's revenue was up 6.0% compared to the same quarter last year. During the same period in the previous year, the company posted $10.12 EPS. McKesson has set its FY 2027 guidance at 43.800-44.600 EPS. As a group, equities analysts expect that McKesson Corporation will post 44.29 earnings per share for the current year.
McKesson Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 1st. Shareholders of record on Monday, June 1st will be paid a $0.82 dividend. This represents a $3.28 annualized dividend and a yield of 0.4%. The ex-dividend date of this dividend is Monday, June 1st. McKesson's payout ratio is currently 8.53%.
Insider Buying and Selling at McKesson
In other McKesson news, EVP Michele Lau sold 3,550 shares of the business's stock in a transaction on Tuesday, May 26th. The shares were sold at an average price of $761.09, for a total value of $2,701,869.50. Following the transaction, the executive vice president directly owned 3,247 shares of the company's stock, valued at approximately $2,471,259.23. The trade was a 52.23% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Thomas L. Rodgers sold 2,388 shares of the business's stock in a transaction on Tuesday, May 26th. The shares were sold at an average price of $761.09, for a total transaction of $1,817,482.92. Following the completion of the transaction, the executive vice president directly owned 3,090 shares in the company, valued at $2,351,768.10. This represents a 43.59% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold a total of 8,663 shares of company stock worth $7,217,102 over the last three months. 0.08% of the stock is currently owned by corporate insiders.
Analysts Set New Price Targets
A number of research firms have weighed in on MCK. Citigroup cut their price objective on shares of McKesson from $975.00 to $945.00 and set a "buy" rating on the stock in a report on Thursday, May 14th. Leerink Partners reissued an "outperform" rating and set a $1,085.00 price objective on shares of McKesson in a report on Thursday, March 5th. Weiss Ratings cut shares of McKesson from a "buy (b+)" rating to a "buy (b)" rating in a report on Monday, May 18th. Raymond James Financial set a $970.00 price objective on shares of McKesson in a report on Thursday, March 5th. Finally, Barclays lifted their target price on shares of McKesson from $960.00 to $1,050.00 and gave the company an "overweight" rating in a report on Wednesday, February 18th. Fourteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat, McKesson currently has a consensus rating of "Moderate Buy" and a consensus price target of $968.87.
Get Our Latest Research Report on McKesson
McKesson Company Profile
(
Free Report)
McKesson Corporation NYSE: MCK is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.
The company's core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider McKesson, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and McKesson wasn't on the list.
While McKesson currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.